Dr. Dorff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4700 Lexington Ave N
Ste C
Shoreview, MN 55126Phone+1 651-756-9595Fax+1 651-340-8529
Summary
- Board certified Family Medicine physician specializing in comprehensive outpatient care for multisystem diseases with further focus on connective tissue disease (Ehlers-Danlos Syndromes, Marfan Syndrome, Myotonia, and Hypermobile Spectrum Disorders), Postural Orthostatic Tachycardia Syndrome, Dysautonomia, Mast Cell Activation Syndrome, Toxicant Induced Loss of Tolerance formerly called Multiple Chemical Sensitivity Syndrome, Myalgic Encephalitis, Chronic Fatigue Syndrome, long COVID, neurodivergence, gender care, and more.
I wrote and published medical literature for medical professionals, published books for patients, and led continuing medical education lectures on the conditions to raise awareness and improve access to care.
Education & Training
- University of Minnesota/University of Minnesota Medical CenterResidency, Family Medicine, 2008 - 2011
- University of Missouri Kansas City School of MedicineClass of 2008
Certifications & Licensure
- MD State Medical License 2022 - 2026
- ND State Medical License 2022 - 2026
- MN State Medical License 2009 - 2025
- SD State Medical License Active through 2025
- WI State Medical License 2018 - 2025
- American Board of Family Medicine Family Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Publications & Presentations
PubMed
- 55 citationsDiagnosis of mast cell activation syndrome: a global "consensus-2".Lawrence B. Afrin, Mary B. Ackerley, Linda S. Bluestein, Joseph H. Brewer, Jill B Brook
Diagnosis. 2021-05-01 - 11 citationsSuccessful mast-cell-targeted treatment of chronic dyspareunia, vaginitis, and dysfunctional uterine bleedingLawrence B. Afrin, Tania T. Dempsey, Lila S. Rosenthal, Shanda R. Dorff
Journal of Obstetrics and Gynaecology. 2019-04-09 - 8 citationsMast cell activation syndrome in pregnancy, delivery, postpartum and lactation: a narrative review.Shanda R. Dorff, Lawrence B. Afrin
Journal of Obstetrics and Gynaecology. 2020-03-09
Books/Book Chapters
Lectures
- Mast Cell Activation Syndrome in Pregnancy, Delivery, Postpartum, and Lactation part 2International webinar CME - 3/2023
- Management of Mast Cell Activation Syndrome in Pregnancy, Delivery, Postpartum, and Lactation part 1New York - 6/2022
- Ehlers-Danlos Syndrome, updates to diagnosis and managementColorado - 4/2019
- Join now to see all
Authored Content
- Diagnosis of mast cell activation syndrome, a global "consensus-2"May 2021
- Mast cell activation syndrome in pregnancy, delivery, postpartum, and lactation: a narrative reviewMarch 2020
- Successful mast-cell-targeted treatment of chronic dyspareunia, vaginitis, and dysfunctional uterine bleedingApril 2019
- EDS GuideMay 2018
- Join now to see all
Press Mentions
- FPs Hammer Out Practice-Related Measures for AAFP to Take UpMay 1st, 2019
Committees
- Member, EDS Society Allergy and Immunology Consortium 2021 - Present
Professional Memberships
- Member
- Member
- Member
- International Society for Environmentally Acquired IllnessesMember
- Ehlers-Danlos SocietyMember
External Links
- Complex Cares LLC https://www.ComplexCaresMN.com
- Instagramhttps://www.instagram.com/zebramd_pandamom/
- Clinic Facebook pagehttps://m.facebook.com/ComplexCares
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: